Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 3013-3019
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3013
Figure 1
Figure 1 Rates of patients achieving a sustained virologic response 24 wk after therapy (sustained virologic response 24). SVR: Sustained virologic response; NR: Non responders were defined by positive HCV-RNA at the end of at least 24 wk of treatment.